tirzepatide real‑world
Prescription Weight Loss Fails Tirzepatide Triumphs Instead
Tirzepatide delivered markedly greater weight loss than older GLP-1 agents in 2023, translating into superior blood-glucose control and a milder side-effect profile. This outcome challenges the modest results of conventional prescription weight-loss drugs, which often fail to sustain metabolic benefits over time. Medical Disclaimer: This article is for informational purposes